T88.8XXS

T88.8XXS: Other specified complications of surgical and medical care, not elsewhere classified, sequela

Billable / specific codeICD-10-CMPOA exempt

T88.8XXS is a billable, specific ICD-10-CM code for other specified complications of surgical and medical care, not elsewhere classified, sequela. It is valid for submission on a claim.

Check T88.8XXS with the rest of the claim: free scrubber

7th character "S": sequela

The appropriate 7th character is to be added to each code from category T88

A: initial encounter
D: subsequent encounter
S: sequela

Use additional code

Add a secondary code to capture the detail described below.

code to identify the complication

Excludes2 inherited from the categories above T88.8XXS

Not part of this code, but both may be coded when both are present.

Written on T88: Other complications of surgical and medical care, not elsewhere classified

complication following infusion, transfusion and therapeutic injection (T80.-)
complication following procedure NEC (T81.-)
complications of anesthesia in labor and delivery (O74.-)
complications of anesthesia in pregnancy (O29.-)
complications of anesthesia in puerperium (O89.-)
complications of devices, implants and grafts (T82-T85)
complications of obstetric surgery and procedure (O75.4)
dermatitis due to drugs and medicaments (L23.3, L24.4, L25.1, L27.0-L27.1)
poisoning and toxic effects of drugs and chemicals (T36-T65 with fifth or sixth character 1-4)
specified complications classified elsewhere

Risk adjustment

No CMS-HCC V28 category: this code does not change a RAF score.

Medicare coverage

T88.8XXS is named in 11 Medicare coverage policies: 11 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.

A53057Billing and Coding: Home Health Occupational Therapy
A53058Billing and Coding: Home Health Physical Therapy
A53064Billing and Coding: Outpatient Occupational Therapy
A53065Billing and Coding: Outpatient Physical Therapy

Code history

Unchanged in every release from FY2024 to FY2027.